About Hoba Therapeutics

Website
Website
Employees
Employees
1-10 employees View all
Industry
Industry
Biotechnology
Location
Location
Ole Maaløes Vej 3, Copenhagen, Capital Region, DK
Description
Information
Hoba Therapeutics was established November 2016 and funded by Novo Seeds and Borean Innovation. The company is developing biopharmaceuticals for the treatment of pain and CNS disorders. Our pipeline includes two patented endogenous neurotrophic factors with shared properties. The lead compound is HB-086 (human recombinant Meteorin) and preclinical studies support therapeutic use in neuropathy and associated neuropathic pain. HB-097 (human recombinant Cometin) is in early preclinical development for hearing disorders. Our mission is to provide innovative effective, safe and disease modifying treatments to patients living with neuropathic pain

Hoba Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Hoba Therapeutics

What is Hoba Therapeutics email format?

The widely used Hoba Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Hoba Therapeutics customer service number?

To contact Hoba Therapeutics customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more